Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

Strowd RE, Cartwright MS, Okun MS, Haq I, Siddiqui MS.

J Neurol. 2010 Aug;257(8):1382-7. doi: 10.1007/s00415-010-5550-3. Epub 2010 Apr 8.

PMID:
20376475
2.

Inappropriate crying and laughing in Parkinson disease and movement disorders.

Siddiqui MS, Fernandez HH, Garvan CW, Kirsch-Darrow L, Bowers D, Rodriguez RL, Jacobson CE 4th, Rosado C, Vaidyanathan S, Foote KD, Okun MS.

World J Biol Psychiatry. 2009;10(3):234-40. doi: 10.1080/15622970701639445.

PMID:
18609421
3.

Laughter, crying and sadness in ALS.

Thakore NJ, Pioro EP.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):825-831. doi: 10.1136/jnnp-2017-315622. Epub 2017 Jun 1.

4.

PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE.

PLoS One. 2013 Aug 21;8(8):e72232. doi: 10.1371/journal.pone.0072232. eCollection 2013.

5.

PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS.

Vidović V, Rovazdi MČ, Kraml O, Kes VB.

Acta Clin Croat. 2015 Jun;54(2):159-63.

PMID:
26415311
6.

Pseudobulbar affect: an under-recognized and under-treated neurological disorder.

Work SS, Colamonico JA, Bradley WG, Kaye RE.

Adv Ther. 2011 Jul;28(7):586-601. doi: 10.1007/s12325-011-0031-3. Epub 2011 Jun 6.

PMID:
21660634
7.

Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residents.

Foley K, Konetzka RT, Bunin A, Yonan C.

Int J Geriatr Psychiatry. 2016 Jul;31(7):694-701. doi: 10.1002/gps.4374. Epub 2015 Nov 2.

8.

Dextromethorphan/quinidine for the treatment of pseudobulbar affect.

Patatanian E, Casselman J.

Consult Pharm. 2014 Apr;29(4):264-9. doi: 10.4140/TCP.n.2014.264. Review.

PMID:
24704895
9.

Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).

Tortelli R, Copetti M, Arcuti S, Tursi M, Iurillo A, Barulli MR, Cortese R, Capozzo R, D'Errico E, Marin B, Simone IL, Logroscino G.

J Neurol. 2016 Feb;263(2):316-321. doi: 10.1007/s00415-015-7981-3. Epub 2015 Nov 20.

PMID:
26588919
10.

Review of pseudobulbar affect including a novel and potential therapy.

Schiffer R, Pope LE.

J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):447-54. Review.

PMID:
16387982
11.

The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting.

Arciniegas DB, Lauterbach EC, Anderson KE, Chow TW, Flashman LA, Hurley RA, Kaufer DI, McAllister TW, Reeve A, Schiffer RB, Silver JM.

CNS Spectr. 2005 May;10(5):1-14; quiz 15-6. Review.

PMID:
15962457
12.

Identification of pseudobulbar affect symptoms in Veterans with possible traumatic brain injury.

Fonda JR, Hunt PR, McGlinchey RE, Rudolph JL, Milberg WP, Reynolds MW, Yonan C.

J Rehabil Res Dev. 2015;52(7):839-49. doi: 10.1682/JRRD.2014.08.0191.

13.

Pseudobulbar affect: burden of illness in the USA.

Colamonico J, Formella A, Bradley W.

Adv Ther. 2012 Sep;29(9):775-98. doi: 10.1007/s12325-012-0043-7. Epub 2012 Aug 30.

PMID:
22941524
14.
15.

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.

Pioro EP.

Neurol Ther. 2014 Jun 17;3(1):15-28. doi: 10.1007/s40120-014-0018-5. eCollection 2014 Jun. Review.

16.

Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients.

Smith RA, Berg JE, Pope LE, Callahan JD, Wynn D, Thisted RA.

Mult Scler. 2004 Dec;10(6):679-85.

PMID:
15584494
17.

Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis.

Patel N, Combs H, York M, Phan C, Jimenez-Shahed J.

J Neuropsychiatry Clin Neurosci. 2018 Summer;30(3):214-219. doi: 10.1176/appi.neuropsych.17070131. Epub 2018 Mar 5.

PMID:
29505320
18.

Involuntary emotional expression disorder (IEED) in Parkinson's disease.

Phuong L, Garg S, Duda JE, Stern MB, Weintraub D.

Parkinsonism Relat Disord. 2009 Aug;15(7):511-5. doi: 10.1016/j.parkreldis.2009.01.001. Epub 2009 Jan 31.

19.

Identification of pseudobulbar affect symptoms in the nursing home setting: Development and assessment of a screening tool.

Allen C, Zarowitz B, O'Shea T, Peterson E, Yonan C, Waterman F.

Geriatr Nurs. 2018 Jan - Feb;39(1):54-59. doi: 10.1016/j.gerinurse.2017.06.002. Epub 2017 Aug 12.

PMID:
28807457
20.

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

Hammond FM, Alexander DN, Cutler AJ, D'Amico S, Doody RS, Sauve W, Zorowitz RD, Davis CS, Shin P, Ledon F, Yonan C, Formella AE, Siffert J.

BMC Neurol. 2016 Jun 9;16:89. doi: 10.1186/s12883-016-0609-0. Erratum in: BMC Neurol. 2016;16(1):160.

Supplemental Content

Support Center